ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2001 • 2018 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor Stimulation Regulates Autophagy in Chondrocytes

    Benjamin Friedman1, Carmen Corciulo2, Cristina Castro3 and Bruce N. Cronstein1, 1Rheumatology, New York University School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3Medicine, NYU School of Medicine, New York, NY

    Background/Purpose: Osteoarthritis (OA) is a debilitating condition characterized by chondrocyte dysfunction and loss of cartilage. Autophagy, a homeostatic process that occurs in times of cellular…
  • Abstract Number: 2002 • 2018 ACR/ARHP Annual Meeting

    Dynamic Compression of Articular Cartilage Explants Increases Formation and Decreases Degradation of Type II Collagen

    Amalie Engstrøm1,2, Anne C. Bay-Jensen2, Morten A. Karsdal2 and Christian S. Thudium2, 1Department of Biomedical Science, University of Copenhagen, København, Denmark, 2Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Mechanical loading is recognized as a major factor in initiation and progression of osteoarthritis (OA). Conversely loading is believed to play an essential role…
  • Abstract Number: 2003 • 2018 ACR/ARHP Annual Meeting

    Chondrocyte Size in Articular Cartilage As a Marker of Osteoarthritis Severity

    Paula Gratal1, Aranzazu Mediero2, Iván Prieto-Potin1, Ana Lamuedra1, Gabriel Herrero-Beaumont1 and Raquel Largo1, 1Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, 2Joint and Bone Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

    Background/Purpose: Terminal differentiating growth plate chondrocytes are mainly characterized by an increase of their cell size and by the expression of hypertrophic markers such as…
  • Abstract Number: 2004 • 2018 ACR/ARHP Annual Meeting

    Effective Inhibition of Metalloproteases By a Viscosupplement Based on a Hyaluronic Acid Amide (HYADD®4)

    Cynthia Secchieri1, Devis Galesso1, Cristian Guarise1, Mauro Pavan1, Stefano Moro2 and Veronica Salmaso2, 1Fidia Farmaceutici, Abano Terme, Italy, 2Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy

    Background/Purpose: Osteoarthritis (OA) is a disease which results in the degeneration of articular cartilage. The progression of OA involves inflammation in the early stage of…
  • Abstract Number: 2005 • 2018 ACR/ARHP Annual Meeting

    Identification of a Human Cartilage Microbial DNA Signature and Characterization of Distinct Microbiome Profiles Associated with Osteoarthritis

    Chris Dunn1,2, Cassandra Velasco1,3, Alexander Rivas4, Madison Andrews3,5, Paul Jacob6 and Matlock A. Jeffries2,7, 1Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4University of Arkansas for Medical Sciences, Little Rock, AR, 5Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 6Oklahoma Sport Science and Orthopedics, Oklahoma City, OK, 7Department of Medicine, Division of Rheumatology, Immunology, and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Osteoarthritis (OA) is both the most common form of arthritis and a leading cause of chronic disability. Bacterial products, including lipopolysaccharide (LPS), have been…
  • Abstract Number: 2006 • 2018 ACR/ARHP Annual Meeting

    Murine Ear Wound Cartilage Superhealer Trait Is Associated with Gut Microbiota Changes and Is Transferable to Non-Healer Mice By Gut Microbiome Transplant

    Chris Dunn1,2, Cassandra Velasco1,3, Madison Andrews3,4, Alexander Rivas5 and Matlock A. Jeffries2,6, 1Rheumatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5University of Arkansas for Medical Sciences, Little Rock, AR, 6Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: MRL/MpJ mice are substantially protected from developing post-traumatic osteoarthritis (OA), a trait with strong correlation to the ability to heal ear wounds. Previous studies…
  • Abstract Number: 2007 • 2018 ACR/ARHP Annual Meeting

    Generation of Human Induced Pluripotent Stem Cell Lines from Patients with Hand Osteoarthritis

    Rocío Castro-Viñuelas1, Clara Sanjurjo-Rodríguez2, María Piñeiro-Ramil2, Tamara Hermida-Gómez3, Francisco Javier De Toro Santos4, Francisco J Blanco5, Isaac Fuentes-Boquete2 and Silvia María Díaz-Prado2, 1Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., A Coruña, Spain, 2Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., A CORUÑA, Spain, 3Grupo de Bioingeniería Tisular y Terapia Celular (CBTTC-CHUAC). CIBER-BBN/ISCIII. Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de Coruña (CHUAC). SERGAS. Universidade de A Coruña, A Coruña, Spain, 4Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., La Coruña, Spain, 5Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

    Background/Purpose: Although hand osteoarthritis (OA) is a worldwide burden, there is no treatment able to cure it. Induced pluripotent stem cells (iPSCs) are considered ideal…
  • Abstract Number: 2008 • 2018 ACR/ARHP Annual Meeting

    Vascular Adhesion Protein-1 (VAP-1) As Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis

    Eirini Bournazou1, Jonathan Samuels2, Hua Zhou3, Svetlana Krasnokutsky Samuels4, Jyoti Patel5, Jenny Bencardino6, Leon Rybak7, Steven Abamson8, Uwe Junker9, Karen Brown1 and Mukundan Attur5, 1Roche Innovation Center, New York, NY, 2Department of Medicine, Divison of Rheumatology, NYU Langone Health, New York, NY, 3Bioinformatics, New York University, New York, NY, 4NYU School of Medicine, New York, NY, 5Rheumatology Research, NYU Langone Orthopedic Hospital, New York, NY, 6Radiology, NYU Langone Medical Center, New York, NY, 7Department of Radiology, NYU Langone Medical Center, New York, NY, 8Rheumatology, NYU Langone Health, New York, NY, 9Roche Innovation Center, Basel, Switzerland

    Background/Purpose: To investigate the expression of vascular adhesion protein -1 (VAP-1) in joint tissues and serum in knee osteoarthritis (OA) patients and examine whether VAP-1…
  • Abstract Number: 2009 • 2018 ACR/ARHP Annual Meeting

    A Novel Role of ZCCHC6 in the Regulation of MMP13 in Experimental Osteoarthritis in Mice

    Mohammad Y Ansari1, Nashrah Ahmad2 and Tariq M Haqqi3, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH, 2School of Biomedical Science, Kent State University, kent, OH, 3Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

    Background/Purpose: Zinc Finger CCHC Domain Containing Protein 6 (ZCCHC6) or Terminal Uridylyltransferase 7 (TUT7) is a member of terminal uridylyltransferase family that mediate terminal uridylation…
  • Abstract Number: 2010 • 2018 ACR/ARHP Annual Meeting

    Anti-Endothelial Cell Antibodies in Pediatric Rheumatic Diseases

    Rie Karasawa1, Toshiko Sato1, Megumi Tanaka1, Mayumi Tamaki1, Kazuo Yudoh1 and James Jarvis2, 1Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, 2Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY

    Background/Purpose: Anti-endothelial cell antibodies (AECA) are antibodies detected in multiple autoimmune and inflammatory diseases. Increased levels of such antibodies may be involved in disease activity…
  • Abstract Number: 2011 • 2018 ACR/ARHP Annual Meeting

    Juvenile Arthritis-Associated Single Nucleotide Polymorphisms Identified on Whole Genome Sequencing Show Enrichment within H3K9me3-Marked Regions

    Shannon O'Leary1, Evan Tarbell2, Kaiyu Jiang3, Tao Liu1,4 and James Jarvis5,6, 1Genetics, Genomics, & Bioinformatics Program, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY, 2Biochemistry, University at Buffalo, Buffalo, NY, 3Pediatrics, University at Buffalo, Buffalo, NY, 4Biochemistry, University at Buffalo Jacobs School of Medicine, Buffalo, NY, 5University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Genetics, Genomics, & Bioinformatics Program, Buffalo, NY, 6Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY

    Background/Purpose: We have found extensive alterations in chromatin accessibility when the CD4+ T cells of children with active polyarticular juvenile idiopathic arthritis (JIA) are compared…
  • Abstract Number: 2012 • 2018 ACR/ARHP Annual Meeting

    The Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) Decreases the Cell Surface Expression of TNFR1

    Shoko Tsuji1, Hidenori Matsuzaki2, Tomoyuki Mukai1, Akiko Nagasu1, Hiroyasu Hirano1, Masanori Iseki3, Takahiko Horiuchi4, Ryuta Nishikomori5 and Yoshitaka Morita1, 1Department of Rheumatology, Kawasaki Medical School, Kurashiki, Okayama, Japan, 2Department of Life Sciences, Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, Hiroshima, Japan, 3Department of Immunology and Molecular Genetics, Kawasaki Medical School, Kurashiki, Okayama, Japan, 4Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 5Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Background/Purpose: TNF Receptor- Associated Periodic Syndrome (TRAPS) is one of the autoinflammatory diseases characterized by recurrent inflammatory episodes. TRAPS is caused by an autosomal dominant…
  • Abstract Number: 2014 • 2018 ACR/ARHP Annual Meeting

    Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (sHLH)

    Chiara Passarelli1, Manuela Pardeo2, Ivan Caiello3, Elisa Pisaneschi1, Antonella Insalaco2, Francesca Minoia4, Andrea Taddio5, Francesco Licciardi6, Antonio Novelli1, Fabrizio De Benedetti7 and Claudia Bracaglia2, 1Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 3Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy, 4Reumatologia Pediatrica, IRCCS Istituto Giannina Gaslini, Genoa, Italy, 5Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", University of Trieste, Trieste, Italy, 6SCDU Pediatria II, Immunoreumatologia, Ospedale Pediatrico Regina Margherita, Turin, Italy, 7IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy

    Background/Purpose: Macrophage activation syndrome (MAS), a severe complication of pediatric rheumatic disease, is currently classified among the secondary forms of HLH (sHLH). Primary HLH (pHLH)…
  • Abstract Number: 2015 • 2018 ACR/ARHP Annual Meeting

    Association of Anti-Ro52 Autoantibodies with Interstitial Lung Disease and More Severe Disease Manifestations in Juvenile Idiopathic Inflammatory Myopathies

    Sara Sabbagh1, Iago Pinal-Fernandez1, Takayuki Kishi2, Ira N. Targoff3, Frederick W. Miller2, Lisa G. Rider2 and Andrew Mammen1,4, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institute of Environmental Health Sciences, National Institutes of Health, Environmental Autoimmunity Group, Bethesda, MD, 3VA Medical Center, University of Oklahoma Health Sciences Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Myositis specific autoantibodies (MSA) and myositis associated autoantibodies (MAA) found in adult and juvenile idiopathic inflammatory myopathies (JIIM) often confer a specific disease phenotype.…
  • Abstract Number: 2016 • 2018 ACR/ARHP Annual Meeting

    The Chromatin Landscape Around the Juvenile Arthritis-Associated CXCR4 Locus Suggests Regulatory Functions and Genetic Roles in Both Innate and Adaptive Immunity

    Laura Easton1, Evan Tarbell2, Kaiyu Jiang3, Kyle Mentkowski4, Shannon O'Leary5, Tao Liu5 and James Jarvis1, 1Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY, 2Biochemistry, University at Buffalo, Buffalo, NY, 3Pediatrics, University at Buffalo, Buffalo, NY, 4Graduate Program in Biological Sciences, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY, 5Genetics, Genomics, & Bioinformatics Program, University at Buffalo Jacobs School of Medicine & Biomedical Sciences, Buffalo, NY

    Background/Purpose: CXCR4 is a recently identified susceptibility locus for juvenile idiopathic arthritis (JIA). The index single nucleotide polymorphism (SNP) used to identify this locus, rs95338,…
  • « Previous Page
  • 1
  • …
  • 1136
  • 1137
  • 1138
  • 1139
  • 1140
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology